{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:48Z","timestamp":1786988088842,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejogrb.2025.113946","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T20:18:08Z","timestamp":1743538688000},"page":"113946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Quinagolide vaginal ring for reduction of endometriotic lesions: Results from the QLARITY trial"],"prefix":"10.1016","volume":"310","author":[{"given":"Antonio","family":"Pellicer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Alberich-Bayarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gamborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Heiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Z.","family":"Bagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejogrb.2025.113946_b0005","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/er.2018-00242","article-title":"Endometriosis","volume":"40","author":"Bulun","year":"2019","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113946_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13669-017-0187-1","article-title":"Endometriosis: epidemiology, diagnosis and clinical management","volume":"6","author":"Parasar","year":"2017","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"9447","key":"10.1016\/j.ejogrb.2025.113946_b0015","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"issue":"10276","key":"10.1016\/j.ejogrb.2025.113946_b0020","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(21)00389-5","article-title":"Endometriosis is a chronic systemic disease: clinical challenges and novel innovations","volume":"397","author":"Taylor","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.113946_b0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jmig.2015.12.017","article-title":"Adenomyosis: what the patient needs","volume":"23","author":"Alabiso","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2025.113946_b0030","unstructured":"World Health Organization. Endometriosis. 2023. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/endometriosis#:\u223c:text=Key%20facts%201%20Endometriosis%20affects%20roughly%2010%25%20%28190,and%20sometimes%20depression%2C%20anxiety%2C%20and%20infertility.%20More%20items. Accessed November 16, 2023."},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113946_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.113946_b0040","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/humrep\/dev157","article-title":"Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal","volume":"30","author":"Vercellini","year":"2015","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.113946_b0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1517\/13543784.2012.683783","article-title":"New trends for the medical treatment of endometriosis","volume":"21","author":"Rocha","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.113946_b0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.fertnstert.2012.07.1103","article-title":"Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers","volume":"98","author":"Novella-Maestre","year":"2012","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.113946_b0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/humrep\/deaa337","article-title":"Use of dopamine agonists to target angiogenesis in women with endometriosis","volume":"36","author":"Pellicer","year":"2021","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.113946_b0060","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1095\/biolreprod.110.084392","article-title":"Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy","volume":"83","author":"Novella-Maestre","year":"2010","journal-title":"Biol Reprod"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113946_b0065","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3390\/ijms23031775","article-title":"Quinagolide treatment reduces invasive and angiogenic properties of endometrial mesenchymal stromal cells","volume":"23","author":"Iampietro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejogrb.2025.113946_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2022.856316","article-title":"Endometriosis-associated angiogenesis and anti-angiogenic therapy for endometriosis","volume":"3","author":"Chung","year":"2022","journal-title":"Front Glob Womens Health"},{"issue":"Supp","key":"10.1016\/j.ejogrb.2025.113946_b0075","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1016\/j.fertnstert.2020.08.239","article-title":"Quinagolide vaginal ring for endometriosis: Results from the clinical phase 1 program","volume":"114(3)","author":"Bagger","year":"2020","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113946_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.fertnstert.2008.04.056","article-title":"High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners","volume":"92","author":"Meuleman","year":"2009","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.113946_b0085","doi-asserted-by":"crossref","first-page":"354.e1","DOI":"10.1016\/j.ajog.2018.12.039","article-title":"Clinical diagnosis of endometriosis: a call to action","volume":"220","author":"Agarwal","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.113946_b0090","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.fertnstert.2016.04.005","article-title":"Magnetic resonance imaging structured reporting in infertility","volume":"105","author":"Montoliu-Fornas","year":"2016","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.113946_b0095","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.7314\/APJCP.2015.16.8.3407","article-title":"Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI","volume":"16","author":"Malek","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113946_b0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1509\/jmkr.38.2.143.18840","article-title":"Response styles in marketing research: a cross-national investigation","volume":"38","author":"Baumgartner","year":"2001","journal-title":"J Market Res"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113946_b0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/002224379202900203","article-title":"Improving rating scale measures by detecting and correcting bias components in some response styles","volume":"29","author":"Greenleaf","year":"1992","journal-title":"J Market Res"},{"key":"10.1016\/j.ejogrb.2025.113946_b0110","first-page":"17","article-title":"Measurement and control of response bias","volume":"Vol 1","author":"Paulhus","year":"1991"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113946_b0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2025.113946_b0120","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry. 2018. Available at: https:\/\/www.fda.gov\/files\/drugs\/published\/Clinical-Trial-Imaging-Endpoint-Process-Standards-Guidance-for-Industry.pdf. Accessed February 29, 2024."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113946_b0125","first-page":"93","article-title":"Radiological evaluation of oncologic treatment response: current update","volume":"3","author":"Prasad","year":"2003","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113946_b0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.contraception.2007.05.091","article-title":"Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging","volume":"76","author":"Bragheto","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.113946_b0135","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.fertnstert.2010.10.024","article-title":"Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia","volume":"95","author":"Gomez","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.113946_b0140","article-title":"The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma","volume":"13","author":"Chen","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ejogrb.2025.113946_b0145","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.5114\/pjr.2021.111048","article-title":"Volumetric measurements of target lesions: does it improve inter-reader variability for oncological response assessment according to RECIST 1.1 guidelines compared to standard unidimensional measurements?","volume":"86","author":"Zimmermann","year":"2021","journal-title":"Pol J Radiol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.113946_b0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13287-023-03524-z","article-title":"Novel therapeutic strategies for injured endometrium: intrauterine transplantation of menstrual blood\u2011derived cells from infertile patients","volume":"14","author":"Hosoya","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ejogrb.2025.113946_b0155","article-title":"The menstrual endometrium: from physiology to future treatments","volume":"3","author":"Watters","year":"2021","journal-title":"Front Reprod Health"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.113946_b0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13244-017-0591-0","article-title":"Endometriosis: clinical features, MR imaging findings and pathologic correlation","volume":"9","author":"Foti","year":"2018","journal-title":"Insights Imaging"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:14:32Z","timestamp":1747638872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S0301211525002118"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113946","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinagolide vaginal ring for reduction of endometriotic lesions: Results from the QLARITY trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.113946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113946"}}